🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The purpose of this study is to evaluate safety, to demonstrate lot-to-lot ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-18
Trial ID
NCT01000974
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The primary objective of the study was to demonstrate the non-inferiority o...
Status
Completed
Location
Investigational Site Number :8260024
Start Date
2018-10-10
Trial ID
NCT03632720
Treatments Being Tested
If your serious vaccine-induced adverse event has been entered in the CDC V...
Status
Unknown
Location
Neuroganics LLC
Start Date
2022-03-15
Trial ID
NCT05095844
Treatments Being Tested
The purpose of this study is to assess the safety and reactogenicity of 3 d...
Status
Completed
Location
De La Salle Health Sciences Institute- DLSUMC
Start Date
2018-07-31
Trial ID
NCT03566940
The purpose of the present study is to demonstrate that the changes in the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-05
Trial ID
NCT00808444
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested